KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Depreciation & Amortization (CF) (2016 - 2026)

AbbVie has reported Depreciation & Amortization (CF) over the past 14 years, most recently at $203.0 million for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 1.46% to $203.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $762.0 million through Dec 2025, changed 0.26% year-over-year, with the annual reading at $762.0 million for FY2025, 0.26% changed from the prior year.
  • Depreciation & Amortization (CF) was $203.0 million for Q4 2025 at AbbVie, up from $192.0 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $223.0 million in Q3 2021 and troughed at $173.0 million in Q4 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $191.5 million (2024), against an average of $193.0 million.
  • The largest YoY upside for Depreciation & Amortization (CF) was 79.13% in 2021 against a maximum downside of 23.79% in 2021.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $173.0 million in 2021, then grew by 13.29% to $196.0 million in 2022, then dropped by 4.59% to $187.0 million in 2023, then grew by 10.16% to $206.0 million in 2024, then dropped by 1.46% to $203.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Depreciation & Amortization (CF) are $203.0 million (Q4 2025), $192.0 million (Q3 2025), and $186.0 million (Q2 2025).